PERI-TRANSPLANT DESENSITIZATION WITH APHERESIS AND RITUXIMAB IN KIDNEY TRANSPLANT RECIPIENTS WITH PREFORMED DONOR-SPECIFIC ANTIBODIES AND A NEGATIVE CDC CROSSMATCH. A SINGLE EXPERIENCE CENTRE.